Turning Point Therapeutics
$50.889876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$50.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.48 (+3.00%) Today
$0.00 (0.00%) As of 7:59 PM EST after-hours
Why Robinhood?
You can buy or sell TPTX and other stocks, options, ETFs, and crypto commission-free!
About TPTX
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. It focuses on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. Read More The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
Employees
50
Headquarters
San Diego, California
Founded
2013
Market Cap
1.82B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
440.83K
High Today
$51.53
Low Today
$49.33
Open Price
$49.60
Volume
526.91K
52 Week High
$58.56
52 Week Low
$24.21
Collections
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
TPTX Earnings
-$0.70
-$0.68
-$0.67
-$0.65
Q2 2019
Q3 2019
Estimated
—
Actual
Available Nov 4, After Hours